Evolving treatment paradigms in recurrent and metastatic head and neck squamous cell carcinoma: the emergence of immunotherapy

被引：1
|
作者：
Faraji, Farhoud [1 ]
Cohen, Ezra E. W. [2 ]
Guo, Theresa W. [1 ]
机构：
[1] UC San Diego Hlth, Gleiberman Head & Neck Canc Ctr, Moores Canc Ctr, Dept Otolaryngol Head & Neck Surg, La Jolla, CA USA
[2] UC San Diego Hlth, Dept Internal Med, Gleiberman Head & Neck Canc Ctr, Moores Canc Ctr,Div Hematol Oncol, La Jolla, CA USA
来源：
TRANSLATIONAL CANCER RESEARCH | 2023年 / 12卷 / 05期
关键词：
Immunotherapy; salvage surgery; head and neck squamous cell carcinoma (HNSCC); HUMAN-PAPILLOMAVIRUS; INVESTIGATORS CHOICE; COMORBIDITY INDEX; MUTATIONAL BURDEN; SURGICAL SALVAGE; PD-1; BLOCKADE; CHECKMATE; 141; OPEN-LABEL; SURVIVAL; CANCER;
D O I：
10.21037/tcr-23-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1353 / 1358
页数：6
相关论文
共 50 条
  • [31] Cost-Effectiveness of Nivolumab in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma
    Zargar, Mahdi
    McFarlane, Thomas
    Chan, Kelvin K. W.
    Wong, William W. L.
    ONCOLOGIST, 2018, 23 (02) : 225 - 233
  • [32] Combination treatment of arsenic trioxide and osimertinib in recurrent and metastatic head and neck squamous cell carcinoma
    Hsieh, Ching-Yun
    Chang, Wei-Chao
    Lin, Ching-Chan
    Chen, Jong-Hang
    Lin, Chen-Yuan
    Liu, Chia-Hua
    Lin, Chen
    Hung, Mien-Chie
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (11): : 5049 - +
  • [33] Comparison of real-world outcomes following immunotherapy in recurrent or metastatic head and neck squamous cell carcinoma with outcomes of randomized controlled trials
    Yalamanchali, Anirudh
    Yang, Kailin
    Roof, Logan
    Lopetegui-Lia, Nerea
    Schwartzman, Larisa M.
    Campbell, Shauna R.
    Woody, Neil M.
    Silver, Natalie
    Koyfman, Shlomo
    Geiger, Jessica L.
    Yilmaz, Emrullah
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2023, 45 (04): : 862 - 871
  • [34] Real-world data of immunotherapy from China in recurrent or metastatic head and neck squamous cell carcinoma
    Zhang, Ximei
    Wang, Peiguo
    Chai, Yanlan
    Zhou, Xuan
    Li, Ping
    Wang, Xudong
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2024, 45 (01)
  • [35] Nutritional status associates with immunotherapy clinical outcomes in recurrent or metastatic head and neck squamous cell carcinoma patients
    Hernando-Calvo, Alberto
    Mirallas, Oriol
    Marmolejo, David
    Saavedra, Omar
    Vieito, Maria
    Pastrana, Juan David Assaf
    Aguilar, Susana
    Bescos, Coro
    Lorente, Juan
    Giralt, Jordi
    Benavente, Sergi
    Temprana-Salvador, Jordi
    Alberola, Margarita
    Dienstmann, Rodrigo
    Garralda, Elena
    Felip, Enriqueta
    Villacampa, Guillermo
    Brana, Irene
    ORAL ONCOLOGY, 2023, 140
  • [36] Multimodality treatment in recurrent/metastatic squamous cell carcinoma of head and neck: current therapy, challenges, and future perspectives
    Pannunzio, Sergio
    Di Bello, Armando
    Occhipinti, Denis
    Scala, Alessandro
    Messina, Gloria
    Valente, Giustina
    Quirino, Michela
    Di Salvatore, Mariantonietta
    Tortora, Giampaolo
    Cassano, Alessandra
    FRONTIERS IN ONCOLOGY, 2024, 13
  • [37] Bibliometric analysis of immunotherapy for head and neck squamous cell carcinoma
    Cai, Xin-Jia
    Zhang, He-Yu
    Zhang, Jian-Yun
    Li, Tie -Jun
    JOURNAL OF DENTAL SCIENCES, 2023, 18 (02) : 872 - 882
  • [38] Immunotherapy in head and neck squamous cell carcinoma: a narrative review
    Sharon, Shay
    Bell, R. Bryan
    FRONTIERS OF ORAL AND MAXILLOFACIAL MEDICINE, 2022, 4 : 1 - 18
  • [39] Systemic treatment of recurrent and/or metastatic squamous cell carcinomas of the head and neck: what is the best therapeutic sequence?
    Saada-Bouzid, Esma
    Peyrade, Frederic
    Guigay, Joel
    CURRENT OPINION IN ONCOLOGY, 2022, 34 (03) : 196 - 203
  • [40] Immunotherapy in head and neck squamous cell carcinoma: An updated review
    Parmar, K.
    Mohamed, A.
    Vaish, E.
    Thawani, R.
    Cetnar, J.
    Thein, K. Z.
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2022, 33
12345